journal article·2025-09

A Snakeberry‐Inspired Photocatalytic Nanoreactor Activates Endogenous Ca 2+ Store for Ca 2+ Overload‐Mediated Cancer Therapy

Yuanhong Ma, Zhaowei Zhang, Dacao Yu, Guolong Sun, Ting Wang, Huijie Yan, Zherui Zhang, Junqiu Liu, Dingcheng Zhu

Small· Volume 21· Issue 38
Publisher page

Abstract

Abstract Activation of ubiquitously expressed inositol trisphosphate receptors (IP 3 Rs) represents a compelling Ca 2+ overload strategy for cancer treatment, featuring intrinsic biosafety, a steep 15 000‐fold Ca 2+ flux gradient, and pan‐cancer applicability. However, it remains underexplored due to challenges in developing on‐demand and sustainable activation modalities that ensure treatment reproducibility while preventing off‐target toxicity. This study presents a novel snakeberry‐like nanoreactor (APF@ZIF‐67) with a porous photocatalytic core for H 2 O 2 generation via a direct one‐step 2e − oxygen reduction reaction and ZIF‐67 protrusions for • OH production. H 2 O 2 oxidizes IP 3 R cysteine residue to release endoplasmic reticulum (ER) Ca 2+ , which rapidly accumulates in mitochondria to cause mitochondrial Ca 2+ overload. Simultaneously, Ca 2+ dyshomeostasis and oxidative stress co‐activate ER stress and subsequent pro‐apoptotic unfolded protein response pathway. ER stress and mitochondrial damage activate inflammatory response and inflammation‐driven senescence, eventually leading to cell apoptosis. Importantly, damaged mitochondrial transfer between tumor cells induces bystander effects and amplifies therapeutic effects. Moreover, dark brown APF@ZIF‐67 enables mild photothermal therapy, synergistically enhancing tumor ablation. In vivo, APF@ZIF‐67 efficiently accumulates in tumors and achieves near‐complete eradication without systemic toxicity. Collectively, this study proposes a novel pan‐cancer endogenous Ca 2+ overload‐mediated therapy via photocatalytic activation of tumor‐inherent Ca 2+ channels.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Extracellular vesicles in disease · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Organosilicon Chemistry and Material Technology Ministry of Education Zhejiang Key Laboratory of Organosilicon Material Technology College of Material Chemistry and Chemical Engineering Hangzhou Normal University Hangzhou Zhejiang Province 311121 China

Department of Orthopaedic Surgery Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang Province 310016 China

Department of Chemistry Zhejiang University Hangzhou Zhejiang Province 310027 China

Funding

National Natural Science Foundation of China

References (82)

Show source-provided references
1. 10.1038/nrc.2017.1810.1038/nrc.2017.18 ↗
2. 10.1038/s41419-017-0179-010.1038/s41419-017-0179-0 ↗
3. 10.1002/adfm.20220929110.1002/adfm.202209291 ↗
4. 10.1002/adma.20231231610.1002/adma.202312316 ↗
5. 10.1002/advs.20230603110.1002/advs.202306031 ↗
6. 10.1021/acsnano.3c0345010.1021/acsnano.3c03450 ↗
7. 10.1016/j.ceca.2023.10275310.1016/j.ceca.2023.102753 ↗
8. 10.1016/j.biomaterials.2024.12302710.1016/j.biomaterials.2024.123027 ↗
9. 10.1038/s41467-023-40954-y10.1038/s41467-023-40954-y ↗
10. 10.1002/adma.20240122210.1002/adma.202401222 ↗
11. 10.1021/acs.nanolett.4c0406110.1021/acs.nanolett.4c04061 ↗
12. 10.1021/acsnano.4c0869010.1021/acsnano.4c08690 ↗
13. 10.1002/bmm2.1204110.1002/bmm2.12041 ↗
14. 10.1016/j.cell.2007.11.02810.1016/j.cell.2007.11.028 ↗
15. 10.1002/adfm.20200850710.1002/adfm.202008507 ↗
16. 10.1002/anie.20231757810.1002/anie.202317578 ↗
17. 10.1016/j.cej.2023.14247810.1016/j.cej.2023.142478 ↗
18. 10.1016/j.isci.2020.10104910.1016/j.isci.2020.101049 ↗
19. 10.1021/acs.nanolett.2c0147210.1021/acs.nanolett.2c01472 ↗
20. 10.1021/acs.nanolett.7b0529210.1021/acs.nanolett.7b05292 ↗
21. 10.1016/j.biomaterials.2025.12331110.1016/j.biomaterials.2025.123311 ↗
22. 10.1126/sciadv.adl026310.1126/sciadv.adl0263 ↗
23. 10.1179/135100005X2166010.1179/135100005X21660 ↗
24. 10.1111/bph.1332210.1111/bph.13322 ↗
25. 10.1002/adfm.20242586610.1002/adfm.202425866 ↗
26. 10.1038/s41563-019-0398-010.1038/s41563-019-0398-0 ↗
27. 10.1002/anie.20221831810.1002/anie.202218318 ↗
28. 10.1002/anie.20230282910.1002/anie.202302829 ↗
29. 10.1002/adfm.20240050610.1002/adfm.202400506 ↗
30. 10.1002/adma.20220515310.1002/adma.202205153 ↗
31. 10.1038/s41467-023-43070-z10.1038/s41467-023-43070-z ↗
32. 10.1002/smll.20210322410.1002/smll.202103224 ↗
33. 10.1021/ja206333w10.1021/ja206333w ↗
34. 10.1016/j.polymdegradstab.2020.10927910.1016/j.polymdegradstab.2020.109279 ↗
35. 10.1002/adfm.20231242910.1002/adfm.202312429 ↗
36. 10.1039/D3SC05179J10.1039/D3SC05179J ↗
37. 10.1002/adfm.20170254610.1002/adfm.201702546 ↗
38. 10.1002/adfm.20170393310.1002/adfm.201703933 ↗
39. Tao L. · Nat. Energy · 2017 · 41 · 417
40. 10.1021/acsami.4c0787710.1021/acsami.4c07877 ↗
41. 10.1016/j.jphotobiol.2011.02.01810.1016/j.jphotobiol.2011.02.018 ↗
42. 10.3390/ijms22211160510.3390/ijms222111605 ↗
43. 10.1002/ange.20231921610.1002/ange.202319216 ↗
44. 10.1002/anie.20240456310.1002/anie.202404563 ↗
45. 10.1002/anie.20231055610.1002/anie.202310556 ↗
46. 10.1021/acs.jpcc.4c0111810.1021/acs.jpcc.4c01118 ↗
47. 10.1021/jacs.9b1287310.1021/jacs.9b12873 ↗
48. 10.1016/j.chemosphere.2023.13836410.1016/j.chemosphere.2023.138364 ↗
49. 10.1002/bmm2.1204310.1002/bmm2.12043 ↗
50. 10.1002/anbr.20230009410.1002/anbr.202300094 ↗
51. 10.1016/j.addr.2025.11559310.1016/j.addr.2025.115593 ↗
52. 10.1038/sj.bjp.070726010.1038/sj.bjp.0707260 ↗
53. 10.1126/science.201768310.1126/science.2017683 ↗
54. 10.1038/s41467-022-29073-210.1038/s41467-022-29073-2 ↗
55. 10.3389/fphar.2022.87920410.3389/fphar.2022.879204 ↗
56. 10.1038/ncb0311-18410.1038/ncb0311-184 ↗
57. 10.1038/ncb273810.1038/ncb2738 ↗
58. 10.1038/s41392-023-01570-w10.1038/s41392-023-01570-w ↗
59. 10.1038/s41577-022-00760-x10.1038/s41577-022-00760-x ↗
60. 10.1038/s41413-024-00375-z10.1038/s41413-024-00375-z ↗
61. 10.1038/nm.400010.1038/nm.4000 ↗
62. 10.1038/nrm.2017.12510.1038/nrm.2017.125 ↗
63. 10.1038/s41598-020-69745-x10.1038/s41598-020-69745-x ↗
64. 10.1016/j.jpha.2024.10114110.1016/j.jpha.2024.101141 ↗
65. 10.1038/s41586-024-08439-010.1038/s41586-024-08439-0 ↗
66. 10.1016/j.phrs.2024.10738210.1016/j.phrs.2024.107382 ↗
67. 10.7150/thno.10192210.7150/thno.101922 ↗
68. 10.1038/s44385-025-00010-410.1038/s44385-025-00010-4 ↗
69. 10.1126/sciadv.adp702210.1126/sciadv.adp7022 ↗
70. 10.1158/2159-8290.CD-22-052310.1158/2159-8290.CD-22-0523 ↗
71. 10.1158/2159-8290.CD-22-052810.1158/2159-8290.CD-22-0528 ↗
72. 10.1016/j.ccell.2023.03.01310.1016/j.ccell.2023.03.013 ↗
73. 10.1039/C6DT01428C10.1039/C6DT01428C ↗
74. 10.1016/j.addr.2018.10.00310.1016/j.addr.2018.10.003 ↗
75. 10.1038/nnano.2009.32610.1038/nnano.2009.326 ↗
76. 10.1038/s41560-023-01218-710.1038/s41560-023-01218-7 ↗
77. 10.1016/j.jcis.2023.02.11810.1016/j.jcis.2023.02.118 ↗
78. 10.1021/acsaem.4c0217110.1021/acsaem.4c02171 ↗
79. 10.1002/adma.20240856010.1002/adma.202408560 ↗
80. 10.1002/bmm2.1201010.1002/bmm2.12010 ↗
81. 10.1002/ange.20230898010.1002/ange.202308980 ↗
82. 10.1021/jacs.4c0717010.1021/jacs.4c07170 ↗